INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in AdultsPRNewsWire • 08/26/25
INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment ConferencePRNewsWire • 08/25/25
INOVIO Reports Second Quarter 2025 Financial Results and Recent Business HighlightsPRNewsWire • 08/12/25
Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)PRNewsWire • 08/11/25
Inovio Pharmaceuticals (INO) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 08/05/25
Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business DevelopmentGlobeNewsWire • 07/01/25
Inovio Pharmaceuticals (INO) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/13/25
INOVIO Reports First Quarter 2025 Financial Results and Recent Business HighlightsPRNewsWire • 05/13/25
Inovio Pharmaceuticals, Inc. (INO) Citizens JMP Life Sciences Conference (Transcript)Seeking Alpha • 05/09/25
Down -11.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Inovio (INO)Zacks Investment Research • 04/01/25
INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational HighlightsPRNewsWire • 03/18/25
INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19PRNewsWire • 03/13/25
INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025PRNewsWire • 03/12/25
Inovio Pharmaceuticals Inc (INO) Oppenheimer 35th Annual Healthcare Life Sciences Conference (Transcript)Seeking Alpha • 02/12/25
Here's Why Inovio (INO) Could be Great Choice for a Bottom FisherZacks Investment Research • 02/12/25